Oncology ImagingArchives
Clinical utility of ultrasound in the assessment of sarcopenia in cancer patients: A cross-sectional study.
Oncology Imaging 1 min.
Sarcopenia, defined as the loss of muscle mass accompanied by reduced strength and/or physical performance, is associated with numerous health risks, including falls, complications, prolonged hospitalization, and increased mortality. In cancer patients, sarcopenia is not only age-related but also aggravated...
Retrospective analysis of [99mTc]Tc-HYNIC-PSMA single photon emission computed tomography CT in patients with prostate cancer.
Oncology Imaging 1 min.
Prostate cancer is one of the most common malignancies in men. While multiparametric MRI is the gold standard for local staging of prostate cancer, accessibility may be limited. The same is true for Prostate Specific Membrane Antigen (PSMA) PET/computed tomography (CT). This study evaluates the diagnostic...
Enhancing prediction accuracy for muscle invasion in bladder cancer using a dual-energy CT-based interpretable model incorporating habitat radiomics and deep learning
Oncology Imaging 6 min.
Bladder cancer (BCa) is the most prevalent malignant tumor in the urinary system, with its incidence increasing globally each year [1, 2]. Based on the depth of muscle invasion, BCa can be categorized into non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC), which exhibit...
Tumor metabolic heterogeneity based on 18F-FDG PET/CT is a predictor of outcome in diffuse large B-cell lymphoma
Oncology Imaging 6 min.
Diffuse large B-cell lymphoma (DLBCL) is the most prevalent pathological subtype of aggressive non-Hodgkin’s lymphoma and accounts for the largest share of lymphoma-related deaths worldwide [1, 2].The standard first-line chemoimmunotherapy of rituximab combined with cyclophosphamide, doxorubicin,...
